Semaglutide, a selective GLP-1 receptor agonist, primarily acts on central appetite regulation and gastric emptying, leading to reduced caloric intake, improved satiety, and clinically meaningful reductions in glycated hemoglobin (1.31.6%) and body weight
Survodutide is another dual GLP-1/glucagon agonist in development
pH 37, citric acid/disodium hydrogen phosphate
Opt for plain toast, crackers, bananas, or oatmeal instead of spicy or greasy foods
BPC-157 and TB-500 therapy is: A powerful, regenerative tool for tissue repair
Dietitians trained in non-diet, intuitive eating, or HAES-aligned care won't hand you a rigid plan and send you off